Cargando…

Are there cognitive and neuroimaging signatures in long COVID?

This scientific commentary refers to ‘Markers of limbic system damage following SARS-CoV-2 infection’, by Thomasson et al. (https://doi.org/10.1093/braincomms/fcad177)

Detalles Bibliográficos
Autores principales:	Matias-Guiu, Jordi A, Díez-Cirarda, María
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Scientific Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320749/ https://www.ncbi.nlm.nih.gov/pubmed/37415777 http://dx.doi.org/10.1093/braincomms/fcad189

Ejemplares similares

Primary progressive aphasia: in search of brief cognitive assessments
por: Matias-Guiu, Jordi A, et al.
Publicado: (2022)

Predominance of visuoconstructive impairment after mild COVID-19?
por: Díez-Cirarda, María, et al.
Publicado: (2022)

Fatigue and Cognitive Dysfunction Are Associated with Occupational Status in Post-COVID Syndrome
por: Delgado-Alonso, Cristina, et al.
Publicado: (2022)

The cognitive aftermath of COVID-19
por: Lleó, Alberto, et al.
Publicado: (2020)

Validation of the European Cross-Cultural Neuropsychological Test Battery (CNTB) for the assessment of mild cognitive impairment due to Alzheimer's disease and Parkinson's disease
por: Delgado-Álvarez, Alfonso, et al.
Publicado: (2023)

Neural basis of visuospatial tests in behavioral variant frontotemporal dementia
por: Delgado-Álvarez, Alfonso, et al.
Publicado: (2022)

FDG-PET-based neural correlates of Addenbrooke’s cognitive examination III scores in Alzheimer’s disease and frontotemporal degeneration
por: Cabrera-Martín, María Nieves, et al.
Publicado: (2023)

Transcranial direct current stimulation for post-COVID fatigue: a randomized, double-blind, controlled pilot study
por: Oliver-Mas, Silvia, et al.
Publicado: (2023)

A convergent subcortical signature to explain the common efficacy of subthalamic and pallidal deep brain stimulation
por: Steiner, Leon A, et al.
Publicado: (2023)

Sleep and future cognitive decline
por: Coulthard, Elizabeth, et al.
Publicado: (2021)

Validation of the cross-cultural dementia screening test in Alzheimer’s disease and Parkinson’s disease
por: Delgado-Álvarez, Alfonso, et al.
Publicado: (2023)

Towards a more cognitive evaluation of progressive aphasias?
por: Renard, Antoine, et al.
Publicado: (2022)

Neuropsychological Predictors of Fatigue in Post-COVID Syndrome
por: Matias-Guiu, Jordi A., et al.
Publicado: (2022)

Investigating cortico-striatal beta oscillations in Parkinson’s disease cognitive decline
por: Hnazaee, Mansoureh Fahimi, et al.
Publicado: (2023)

Cholinergic neurotransmitter system: a potential marker for post-stroke cognitive recovery
por: Geranmayeh, Fatemeh
Publicado: (2022)

Neurorehabilitation in Parkinson's Disease: A Critical Review of Cognitive Rehabilitation Effects on Cognition and Brain
por: Díez-Cirarda, María, et al.
Publicado: (2018)

An anti-amyloid therapy works for Alzheimer’s disease: why has it taken so long and what is next?
por: Hardy, John, et al.
Publicado: (2023)

Efficacy of cognitive rehabilitation in Parkinson's disease
por: Díez-Cirarda, María, et al.
Publicado: (2018)

Data sharing and publishing in the field of neuroimaging
por: Breeze, Janis L, et al.
Publicado: (2012)

Cognitive dysfunction associated with COVID-19: A comprehensive neuropsychological study
por: Delgado-Alonso, Cristina, et al.
Publicado: (2022)

How COVID-19 affects microvessels in the brain
por: Wenzel, Jan, et al.
Publicado: (2022)

Neuroimaging candidate endophenotypes of social anxiety disorder
por: Yang, Xiyue, et al.
Publicado: (2021)

Inflammatory brain injury after severe viral infection is not unique to COVID-19
por: Bauer, Angelika, et al.
Publicado: (2022)

Long‐term effects of cognitive rehabilitation on brain, functional outcome and cognition in Parkinson's disease
por: Díez‐Cirarda, M., et al.
Publicado: (2017)

Neuroimaging in Parkinsonism: Insights and Challenges
por: Sharma, Vibhash D.
Publicado: (2023)

Functional Components of Cognitive Impairment in Multiple Sclerosis: A Cross-Sectional Investigation
por: Matias-Guiu, Jordi A., et al.
Publicado: (2017)

The Importance of Considering Model Choices When Interpreting Results in Computational Neuroimaging
por: Sprague, Thomas C., et al.
Publicado: (2019)

A Neuroimaging Signature of Cognitive Aging from Whole‐Brain Functional Connectivity
por: Jiang, Rongtao, et al.
Publicado: (2022)

Estimation of Cognitive Performance Based on Premorbid Intelligence in Parkinson’s Disease
por: Del Pino, Rocio, et al.
Publicado: (2020)

An epigenetic signature to fight COVID-19
por: Herbein, Georges
Publicado: (2021)

Potential COVID-19 infection in patients with severe multiple sclerosis treated with alemtuzumab
por: Matías-Guiu, Jorge, et al.
Publicado: (2020)

Cognitive Processes Underlying Verbal Fluency in Multiple Sclerosis
por: Delgado-Álvarez, Alfonso, et al.
Publicado: (2021)

Perovskites take the lead in local structure analysis
por: Keen, David A.
Publicado: (2016)

Increasing complexity: structural equivalence and combinatorial approaches to preparation of high order cocrystals
por: Bourne, Susan A.
Publicado: (2021)

Making sense of SFX data: standards for data and structure validation for a non-standard experiment that has come of age
por: Smith, Clyde A.
Publicado: (2021)

Stimulating cingulate: distinct behaviours arise from discrete zones
por: Apps, Matthew A J
Publicado: (2018)

Phasing tiny crystals
por: Miao, Jianwei, et al.
Publicado: (2013)

Neurofilament light chain: defining the analyte
por: Leckey, Claire A., et al.
Publicado: (2022)

Predicting long-term cardiometabolic risk: Do childhood metabolomic signatures hold the key?
por: Robinson, George A, et al.
Publicado: (2021)

Preclinical Alzheimer’s disease: how to predict who will decline next year?
por: Hanseeuw, Bernard J, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fpbb648e3342c9cv3pm64mvlhl